Method and pharmaceutical composition for chondrostimulation wit

Details Method and pharmaceutical composition for chondrostimulation wit Method and pharmaceutical composition for chondrostimulation wit

1997-06-19

2000-10-17

Krass, Frederick

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 8, 514530, 514573, 514885, A61K 3818, A61K 31557

Patent

active

061332305

ABSTRACT:
A pharmaceutical composition comprising a prostaglandin such as misoprostol and TGF-B in amounts sufficient to stimulate production of chondrocyte matrix is disclosed which exhibit therapeutic synergy.

REFERENCES:
Nicholson, J. Rheumatol, vol. 17, No. suppl. 20, (1990).
Dingle, J. Lipid Mediat, vol. 6, No. 1-3, (1993).
Neidel et al., Arch Orthop Trauma Surg., vol. 114, No. 1, pp. 43-48, (1994).
Brandt, Am J Med, 83:29-34, (1987).
Franceschi et al., Agents and Actions, 29:39-47, (1990).
Ohtani, Med J. Kinki Univ., vol. 18, No. 2, pp. 241-252, (1993).
Diaz, et al., Ann NY Acad Sci, 593:306-309, (1990).
Tyler, Biochem J, 260:543-548, (1989).
Morales, et al., J Biol Chem, 236:12828-12831, (1988).
Howard, et al., J Rheumatol, 20:2083-2094, (1993).
Dingle, J Rheumatol, 18(Suppl. 28):30-37, (1991).
Brandt, et al., J Clin Pharmacol, 31:673-676, (1991).
Athanassiades et al., In vitro Cell Develop Biol, 30A:510-511, (1994).
D. Heingard, et al., Methods Enzymol, 145:336-363, (1987).
Hronowski, et al., J Biol Chem, 255:9210-9217, (1980).
Hronowski, et al., Anal Biochem, 93:60-72, (1979).
Palmoski, et al., Arthritis Rheum, 23:83-91, (1980).
Muir, et al., Drugs, 35 (suppl. 1):15-23, (1988).
Slowman-Kovacs, et al., Arthritis Rheum, 26:528-531, (1989).
Kuettner, et al., J Cell Biol, 93:743-750, (1982).
Shield, Scand J Rheumatol Suppl, 92:31-52, (1992).
Sirois, et al., J Biol Chem, 267:6382-6388, (1992).
Vane, et al, Adv Prostaglandin, Thromboxane Leukot Res, 23:41-48, (1995).
Karim, Prostaglandins, 33 (Supp.):40-50, (1987).
Dingle, Adv Prostaglandin, Thromboxane and Leukot Res, 21B:955-966, (1990).
Colombo, et al., Arthritis Rheum, 26:1132-1139, (1983).
Palmoski, et al., Arthritis Rheum, 26:771-774, (1983).
Herman, et al., J Rheumatol, 13:1014-1018, (1986).
Kararli et al., Adv Exp Med Biol, 302:275-289, (1991).
Geng, et al., J Immunol, 155:796-801, (1995).
Osborn, et al., J Orthop Res, 7:35-42, (1989).
Huskisson, et al., J Rheumatol, 22:1941-1946, (1995).
T. Anastassiades et al., The Journal of Rheumatology, 1998 vol. 25(10) pp. 1962-1967.
R.L. Smith, Editorial, The Journal of Rheumatology, 1998 vol. 25(10) pp. 1871-1873.
Chopra et al., Arthritis & Rheumatsm, vol. 38, No. 9 Suppl. p. S161 1950 (Abstract), Oct. 21, 1995.
Andrews et al--Biochem. Biophys. Res. Commun. vol. 162, No. 1 pp. 144-150, Jul. 1989.

Affiliated with

Also associated with

Rating

Method and pharmaceutical composition for chondrostimulation wit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and pharmaceutical composition for chondrostimulation wit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and pharmaceutical composition for chondrostimulation wit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-468907